Healthcare | April 25, 2026
Vision 360 brings academia, industry together to advance ophthalmic therapies
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
The system is powered by BrainSense technology, which has received approval from USFDA
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
PMDA is regarded among the most stringent regulatory bodies globally
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Subscribe To Our Newsletter & Stay Updated
